Loading...

Loading...

Vallejo-i: Mexico City Industry and Innovation Cluster
By Fadlala Akabani - Mon, 05/02/2022 - 11:00
The industrial powerhouse of Mexico is rising once again thanks to a forward-looking strategy linked to Industry 4.0, writes Fadlala Akabani Hneide.
https://mexicobusiness.news/tag/grupo-neolpharma
More Health
Nearshoring Opportunities for the Mexican Health Industry
By Miriam Bello - Fri, 08/13/2021 - 15:38
COVID-19 has sparked opportunities for already promising sectors of the Mexican economy.
Local Production to Boost National Self-Reliance
By - Thu, 04/29/2021 - 15:33
Grupo Neolpharma prepares to inaugurate a new injectables plant, while it studies the construction of a new facility for API production.
Investment Responds to Patient, Market and Industry Needs
By Miriam Bello - Fri, 11/20/2020 - 09:30
Strategic investment has made Grupo Neolpharma an important partner for both the public and private sectors. Learn why.
Early Studies on Long-Term COVID-19 Effects Come To Light
By Miriam Bello - Thu, 07/23/2020 - 13:12
Recent findings highlight more reasons to remain safe from COVID-19 contagion. Others give hope of a possible cure.
Strategies to Address Limited Access to Care
By - Wed, 09/05/2018 - 11:34
Grupo Neolpharma is a Mexican pharmaceutical group that incorporates three companies: Psicofarma, Neolpharma and Alpharma.
Future of Healthcare: Made-in-Mexico Research
By - Wed, 09/05/2018 - 10:01
CINVESTAV one of Mexico’s largest academic institutes, performs research in many different fields and offers several masters and Ph.D programs.
How Can the Private Sector Promote a Better-Educated Workforce?
By - Thu, 09/07/2017 - 15:02
MHR asked 7 leaders from companies working in the healthcare sector about their contributions to improving Mexican health talent.
Prize Stimulates R&D Innovation Biotech, Nanotech
By - Wed, 09/06/2017 - 10:41
Grupo Neolpharma is a Mexican group that comprises several pharmaceutical companies
Neolpharma Growth Poised on Cardio-Metabolics
By - Wed, 09/07/2016 - 09:36
Grupo Neolpharma’s growth rate slightly surpasses the market average.